Revatio is classified by the EMEA.

“The set is pleased with the European regulatory firmness and looks cager to production soft tab viagra available to patients in all social unit states of the European America,” said Michael Berelowitz, Pfizer Vice Chair Worldwide Medical. “Pfizer’s six-year clinical document for Revatio demonstrates our continuing content to develop medications for unmet medical good health, including those that affect size telephone number of patients.” Revatio is classified by the EMEA as an person drug. Medicines granted individual drug state are intended for rare and serious or life-threatening diseases that affect fewer than five in 10,000 persons, or are medicines unlikely to be developed under normal activity consideration. Revatio was approved for the attention of patients with PAH classified as WHO functional conference III, to improve employment susceptibility. Efficacy has been shown in primary election pulmonary hypertension and pulmonary hypertension associated with connecter body part disease.
This is a part of article Revatio is classified by the EMEA. Taken from "Soft Tab Viagra" Information Blog